Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
The objective of this study is to assess the safety and effectiveness of the Cordis Bilateral AAA device and its Delivery System compared to open surgical repair for the treatment of Abdominal Aortic Aneurysm (AAA).
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| Cordis AAA Bilateral Device | Device |
| Measure | Description | Time Frame |
|---|---|---|
| Primary success is defined as freedom from all of the following: rupture of aneurysm, enlargement of aneurysm > 0.5 cm on CT scan, with or without endoleak, as compared to any previous measurement, symptomatic aneurysm requiring treatment. | ||
| The absence of major complications at thirty days defined as arterial thrombosis, respiratory impairment, renal failure, myocardial infarction (M.I.) and stroke in combination with the absence of major complications at one year. |
| Measure | Description | Time Frame |
|---|---|---|
| · Technical success defined as the successful access and deployment of the device at the appropriate anatomic location with aneurysmal exclusion determined by angiography at the time of deployment. |
Not provided
Inclusion Criteria:
- Anatomic (stent-graft)
Aortic Aneurysm Diameter
Aortic Neck
Angulation Neck Length < 45° > 15 mm <60° > 25 mm
Iliac Arteries
Diameter Aortic Neck Common Iliac 26-28 mm 13-18 mm 23-25.9 mm 10-17 mm 20-22.9 mm 9-15 mm 17-19.9 mm 8-13 mm 14-16.9 mm 8-11mm
*NOTE: An aortic diameter cannot be treated if the iliac diameter is not in the same range (e.g. 26-28 mm aortic necks must be in conjunction with 13-18 mm common iliacs).
Anatomic (surgical controls)
· Surgical controls will be required to meet only the aortic or aorto-iliac aneurysm size requirements for anatomic inclusion criteria.
Aortic Aneurysm Diameter
Surgical control patients will be required to meet all of the above-stated stent-graft clinical inclusion criteria.
Exclusion Criteria:
Anatomic (stent-graft)
Aortic Aneurysm Diameter
· < 4.5 cm that are not at least 1.5 times the diameter of the aorta with evidence of a size increase of 5 mm or greater within a six month period.
Aorto-iliac Aneurysms
Aortic Neck
Diameter < 17 mm and > 28 mm (Phase I)
Diameter < 14 and >28 (Phase II)
Thrombus lined
Highly calcified
Iliac Arteries
< 8 mm and > 18 mm (native) (Phase I and Phase II)
Highly calcified (common)
Neither common iliac artery with a cuff > 15 mm.
Anatomic (surgical controls)
· Surgical controls will be excluded based only on the aortic or aorto-iliac aneurysm size requirements for anatomic exclusion criteria.
Aortic Aneurysm Diameter
· < 4.5 cm that are not at least 1.5 times the diameter of the aorta with evidence of a size increase of 5 mm or greater within a six month period.
Aorto-Iliac Aneurysms
Clinical (stent-graft)
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Affiliation | Role |
|---|---|---|
| Michael Marin, MD | MOUNT SINAI HOSPITAL | Principal Investigator |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Mt. Sinai Hospital | New York | New York | 10029 | United States |
Not provided
| ID | Term |
|---|---|
| D017544 | Aortic Aneurysm, Abdominal |
| ID | Term |
|---|---|
| D001014 | Aortic Aneurysm |
| D000783 | Aneurysm |
| D014652 | Vascular Diseases |
| D002318 | Cardiovascular Diseases |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| D001018 |
| Aortic Diseases |